Correlation Between Vaxart and Oncotelic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vaxart and Oncotelic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxart and Oncotelic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxart Inc and Oncotelic Therapeutics, you can compare the effects of market volatilities on Vaxart and Oncotelic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxart with a short position of Oncotelic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxart and Oncotelic Therapeutics.
Diversification Opportunities for Vaxart and Oncotelic Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vaxart and Oncotelic is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Vaxart Inc and Oncotelic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncotelic Therapeutics and Vaxart is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxart Inc are associated (or correlated) with Oncotelic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncotelic Therapeutics has no effect on the direction of Vaxart i.e., Vaxart and Oncotelic Therapeutics go up and down completely randomly.
Pair Corralation between Vaxart and Oncotelic Therapeutics
Given the investment horizon of 90 days Vaxart is expected to generate 13.47 times less return on investment than Oncotelic Therapeutics. But when comparing it to its historical volatility, Vaxart Inc is 3.16 times less risky than Oncotelic Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Oncotelic Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 3.00 in Oncotelic Therapeutics on August 31, 2024 and sell it today you would lose (0.80) from holding Oncotelic Therapeutics or give up 26.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 8.56% |
| Values | Daily Returns |
Vaxart Inc vs. Oncotelic Therapeutics
Performance |
| Timeline |
| Vaxart Inc |
| Oncotelic Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vaxart and Oncotelic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaxart and Oncotelic Therapeutics
The main advantage of trading using opposite Vaxart and Oncotelic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxart position performs unexpectedly, Oncotelic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncotelic Therapeutics will offset losses from the drop in Oncotelic Therapeutics' long position.| Vaxart vs. Cue Biopharma | Vaxart vs. Eliem Therapeutics | Vaxart vs. Inhibrx | Vaxart vs. Molecular Partners AG |
| Oncotelic Therapeutics vs. Processa Pharmaceuticals | Oncotelic Therapeutics vs. Advanced Proteome Therapeutics | Oncotelic Therapeutics vs. Cellectis SA | Oncotelic Therapeutics vs. ChitogenX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |